HistoSonics gets Taiwan approval for its tumour-destroying ultrasound system as it pushes into Asia
HistoSonics has received regulatory approval from Taiwan’s Food and Drug Administration for its Edison Histotripsy System, a non-invasive cancer treatment device that uses focused ultrasound to destroy tumours without cutting, radiation, or thermal damage. The TFDA authorisation, announced on 18…
No discussion yet. Be the first to share your thoughts!